Kirstin Stricker

1.9k total citations · 1 hit paper
21 papers, 1.6k citations indexed

About

Kirstin Stricker is a scholar working on Immunology, Molecular Biology and Pharmacology. According to data from OpenAlex, Kirstin Stricker has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Kirstin Stricker's work include Inflammatory mediators and NSAID effects (4 papers), Immune Cell Function and Interaction (3 papers) and Malaria Research and Control (3 papers). Kirstin Stricker is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Immune Cell Function and Interaction (3 papers) and Malaria Research and Control (3 papers). Kirstin Stricker collaborates with scholars based in Switzerland, United States and Germany. Kirstin Stricker's co-authors include Klaus‐Michael Debatin, Michael O. Westendorp, Jens Dhein, Henning Walczak, Rainer Frank, Christina Ochsenbauer, P H Krammer, Wulf Dröge, Marek Łoś and Klaus Schulze‐Osthoff and has published in prestigious journals such as Nature, Blood and The Journal of Immunology.

In The Last Decade

Kirstin Stricker

21 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120

1995 844 citations Michael O. Westendorp, Rainer Frank et al. Nature profile →

Peers

Countries citing papers authored by Kirstin Stricker

Since Specialization

Citations

This map shows the geographic impact of Kirstin Stricker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirstin Stricker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirstin Stricker more than expected).

Fields of papers citing papers by Kirstin Stricker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirstin Stricker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirstin Stricker. The network helps show where Kirstin Stricker may publish in the future.

Co-authorship network of co-authors of Kirstin Stricker

This figure shows the co-authorship network connecting the top 25 collaborators of Kirstin Stricker. A scholar is included among the top collaborators of Kirstin Stricker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirstin Stricker. Kirstin Stricker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Continuous remote home monitoring solutions for mother and fetus: A scoping review 2024 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·Kirstin Stricker, Anda‐Petronela Radan, Daniel Surbek	3
2	Combating poor-quality anti-malarial medicines: a call to action 2016 ·Malaria Journal ·Quique Bassat, Marcel Tanner, Philippe J. Guérin, Kirstin Stricker, Kamal Hamed	44
3	Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria 2015 ·Antimicrobial Agents and Chemotherapy ·Quique Bassat, Bernhards Ogutu, Abdoulaye Djimdé, Kirstin Stricker, Kamal Hamed	10
4	Development of a pediatric formulation for treatment of P. falciparum malaria: Coartem® (artemether-lumefantrine) Dispersible 2014 ·Malaria Journal ·Quique Bassat, Bernhards Ogutu, Abdoulaye Djimdé, Kirstin Stricker, Kamal Hamed	1
5	Metabolic and crystal arthropathies: 112. Rapid Improvement in Health-Related Quality of Life in Gouty Arthritis Patients Treated with Canakinumab (ACZ885) Compared to Triamcinolone Acetonide 2011 ·Lara D. Veeken ·(unknown), Marc De Meulemeester, A. Pikhlak, Eftal Yücel, (unknown), (unknown), Udayasankar Arulmani, (unknown), Kirstin Stricker, A. Ferreira, V. Murphy, Peter Sallstig, Naomi Schlesinger, (unknown), Е. Л. Насонов, Jozef Rovenský, Eduardo Mysler, Gerhard Krammer, Alison Balfour, (unknown), (unknown)	3
6	Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) 2011 ·Arthritis Research & Therapy ·Jasmin Kuemmerle‐Deschner, Eduardo Ramos, Norbert Blank, Joachim Roesler, (unknown), Thomas Jung, Kirstin Stricker, Abhijit Chakraborty, Stacey Tannenbaum, A. Wright, Christiane Rordorf	85
7	A Comparison of the Blood Pressure Changes of Lumiracoxib With Those of Ibuprofen and Naproxen 2008 ·Journal of Clinical Hypertension ·Michael E. Farkouh, Freek W.A. Verheugt, Sean Ruland, Howard S. Kirshner, Raban Jeger, Xavier Gitton, Gerhard Krammer, Kirstin Stricker, Peter Sallstig, B. Mellein, Patrice Matchaba, James H. Chesebro	5
8	A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients 2008 ·BMC Musculoskeletal Disorders ·Kirstin Stricker, (unknown), Gerhard Krammer	7
9	Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti‐inflammatory drugs early after the initiation of treatment – findings from the Therapeutic Arthritis Research and Gastrointestinal Event Trial 2008 ·Alimentary Pharmacology & Therapeutics ·C J Hawkey, W.M. Weinstein, Kirstin Stricker, V. Murphy, D. Richard, Gerhard Krammer, (unknown)	6
10	Efficacy and Tolerability of Lumiracoxib 200 mg Once Daily for Treatment of Primary Dysmenorrhea: Results from Two Randomized Controlled Trials 2008 ·Journal of Women s Health ·Stephen Daniels, Xavier Gitton, (unknown), Kirstin Stricker, (unknown)	16
11	Effect of Risk Factors on Complicated and Uncomplicated Ulcers in the TARGET Lumiracoxib Outcomes Study 2007 ·Gastroenterology ·Christopher J. Hawkey, Wilfred M. Weinstein, Walter Smalley, Xavier Gitton, Peter Sallstig, Kirstin Stricker, Gerhard Krammer, B. Mellein, Dominik Richard, Patrice Matchaba	17
12	Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus Type 1 (HIV-1)-infected children 1998 ·Cell Death and Differentiation ·Kirstin Stricker, (unknown), Thomas Böhler, Axel Benner, Peter H. Krammer, Klaus‐Michael Debatin	20
13	Hydrogen peroxide as a potent activator of T lymphocyte functions 1995 ·European Journal of Immunology ·Marek Łoś, Wulf Dröge, Kirstin Stricker, Patrick A. Baeuerle, Klaus Schulze‐Osthoff	172
14	Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 breakdown → 1995 ·Nature ·Michael O. Westendorp, Rainer Frank, Christina Ochsenbauer, Kirstin Stricker, Jens Dhein, Henning Walczak, Klaus‐Michael Debatin, P H Krammer	844
15	Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias 1995 ·Blood ·(unknown), Klaus‐Michael Debatin, Kirstin Stricker, B. Heilig, Astrid Eder, PH Krammer	129
16	Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS. 1995 ·PubMed ·Jens Dhein, Henning Walczak, Michael O. Westendorp, Caroline Bäumler, Kirstin Stricker, Ronald Frank, Klaus‐Michael Debatin, Peter H. Krammer	11
17	The Role of APO‐1‐Mediated Apoptosis in the Immune System 1994 ·Immunological Reviews ·Peter H. Krammer, Jens Dhein, Henning Walczak, Iris Behrmann, Sara M Mariani, Bernd Matiba, Michael Fath, Peter T. Daniel, (unknown), Michael O. Westendorp, Kirstin Stricker, Caroline Bäumler, (unknown), Matthias Germer, Marcus E. Peter, (unknown)	201
18	Activation of the mouse IL-2 gene by okadaic acid: synergy with interleukin-1 1994 ·PubMed ·Werner Falk, Kirstin Stricker, (unknown), Yasumasa Tsukitani, Peter H. Krammer, Michael Stoeck	7
19	[Postoperative urinary retention]. 1991 ·PubMed ·Kirstin Stricker, (unknown)	11
20	In vitro T cell hyperreactivity in Obese strain (OS) chickens is due to a defect in nonspecific suppressor mechanism(s). 1985 ·The Journal of Immunology ·G Krömer, Konrad Schauenstein, Nikolaus Neu, Kirstin Stricker, Georg Wick	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact